Survivin As an Immunohistochemical Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis
OBJECTIVE Genome-level research qualifies survivin as the fourth-best “transcriptome” for colon, lung, brain, breast, and melanoma cancers. To date, it has been stated as a prognostic marker and therapeutic target in colorectal cancer (CRC). However, researchers on survivin expression in CRC are het...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Istanbul Tip Fakultesi
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |